Lance trial publication
Published: 6 February 2024| Version 1 | DOI: 10.17632/64strcdfjh.1
Contributor:
Georgios EvangelouDescription
This dataset includes patient data from the LANCE study to facilitate reproducibility and data reuse. The data encompasses patient outcomes in terms of overall survival and progression-free survival, as well as detailed information on gender, age, time to treatment, Performance Status, and immunohistochemical positivity for TP53, RB1, and Ki67%. Additionally, it includes data on each patient's treatment regimen. Also included are plasma levels of miR375 before and after treatment. Furthermore, the dataset contains the R codes used for data analysis and findings of the study.
Files
Institutions
National and Kapodistrian University of Athens
Categories
Treatment of Small Cell Lung Cancer